Marimed COO Timothy Shaw Receives RSU Award

What Happened Timothy Shaw, Chief Operating Officer of Marimed Inc. (MRMD), received an award of 170,625 restricted stock units (RSUs) on April 15, 2026. The RSUs were granted in lieu of a cash payment for a portion of his annual bonus for the fiscal year ended December 31, 2025. The award is recorded at $0.00 per share (compensation grant/derivative award), and RSUs convert to common stock on a one-for-one basis.

Key Details

• Transaction date and reporting: Grant dated April 15, 2026; Form 4 filed April 17, 2026 (timely).
• Award size and price: 170,625 RSUs; grant price reported as $0.00 (compensatory award).
• Vesting schedule: RSUs vest in four equal installments on July 15, 2026; October 15, 2026; January 15, 2027; and April 15, 2027 (per footnote).
• Conversion: RSUs convert to common stock 1-for-1 (per footnote).
• Ownership note: Footnote states the reporting person’s spouse is trustee of an irrevocable trust holding shares for the reporting person’s children; the reporting person disclaims beneficial ownership of those trust shares.
• Shares owned after transaction: Not specified in the filing.

Context This is a compensation award (RSUs) rather than a market purchase or sale. RSU grants reflect executive compensation and will only become actual shares as they vest; they do not represent an immediate buy or sell of Marimed stock. The filing does not indicate immediate sale or cashless exercise — it documents a grant tied to the executive’s bonus.